• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

CVS Health

CVS to double drive-thru COVID-19 testing sites

September 17, 2020 By Sean Whooley

CVS Health (NYSE:CVS) announced today that it plans to add more than 2,000 new COVID-19 drive-thru test sites at select locations around the U.S. Currently, CVS manages the largest number of independently run COVID-19 test sites in the country, according to a news release. It expects that the 2,000 new locations will just about double its […]

Filed Under: Business/Financial News, Diagnostics, Featured, Genomics/Molecular Diagnostics Tagged With: coronavirus, COVID-19, CVS Health

SmileDirectClub sets $20.50 per-share midpoint for $1.5B IPO

September 9, 2019 By Sean Whooley

SmileDirectClub today set the pricing range on an initial public offering that could fetch up to $1.5 billion. Nashville, Tenn.-based SmileDirectClub produces 3D-printed clear dental aligners designed to provide an alternative to traditional braces. It boasts affordable orthodontic solutions, comparing its price of less than $2,000 to the $5,000 to $8,000 charged for traditional braces. […]

Filed Under: Business/Financial News, Dental, Featured, Funding Roundup, News Well, Wall Street Beat Tagged With: aligntechnology, CVS Health, smiledirectclub

Judge clears CVS to buy Aetna for $70B

September 5, 2019 By Nancy Crotti

A federal judge has approved CVS Health’s (NYSE:CVS) $70 billion acquisition of health insurer Aetna (NYSE:AET). Judge Richard Leon of the U.S. District Court for the District of Columbia had threatened to delay or kill the merger in December over antitrust concerns. The American Medical Association, among others, had expressed concerns about the deal. The […]

Filed Under: Business/Financial News, Featured, Mergers & Acquisitions, News Well Tagged With: Aetna, CVS Health

SmileDirectClub sets range on $1.5B IPO

September 4, 2019 By Sean Whooley

SmileDirectClub yesterday set the pricing range on an initial public offering that could fetch up to $1.5 billion. Nashville, Tenn.-based SmileDirectClub produces 3D-printed clear dental aligners designed to provide an alternative to traditional braces. It boasts affordable orthodontic solutions, comparing its price of less than $2,000 to the $5,000 to $8,000 charged for traditional braces. […]

Filed Under: Business/Financial News, Dental, Featured, Funding Roundup, News Well, Wall Street Beat Tagged With: aligntechnology, CVS Health, smiledirectclub

CVS launches trial for HemoCare home dialysis device

July 17, 2019 By Brad Perriello

CVS Health (NYSE:CVS) launched a clinical trial of the home hemodialysis device it developed in conjunction with Dean Kamen’s Deka Research & Development, aiming to capitalize on the federal government’s plan to overhaul the way kidney disease is treated in the U.S. CVS said the 70-patient study is designed to evaluate the safety and efficacy of […]

Filed Under: Dialysis, Featured, Wall Street Beat Tagged With: CVS Health

CVS to shut down its hearing aid centers nationwide

March 5, 2019 By Nancy Crotti

(NYSE:CVS) plans to close its hearing centers across the U.S. ahead of an anticipated FDA move to allow the sale of over-the-counter hearing aids. The drugstore chain began offering audiology services in a few stores in Ohio and Texas in 2015, expanding to 50 stores nationwide with the majority in California and Florida, according to […]

Filed Under: Business/Financial News, Featured, Food & Drug Administration (FDA), News Well, Wall Street Beat Tagged With: Costco Wholesale Corp., CVS Health, FDA

Judge threatens to delay or even spike $70m CVS-Aetna merger

December 3, 2018 By Brad Perriello

A federal judge last week reportedly threatened to derail the already-closed $70 billion buyout of health insurer Aetna (NYSE:AET) by CVS Health (NYSE:CVS), saying he felt “kept in the dark, kind of like a mushroom.” At a normally routine hearing last week prior to approving the deal, Judge Richard Leon, of the U.S. District Court for the District of Columbia, […]

Filed Under: Featured, Mergers & Acquisitions, Wall Street Beat Tagged With: Aetna, CVS Health

Siemens, CVS, Athenahealth back new Pa.-based medtech accelerator

June 8, 2018 By Fink Densford

Siemens (NYSE:SI), CVS Health (NYSE:CVS) and Athenahealth (NYSE:ATHN) have joined on as backers of Smart Health Innovation Lab, a new Lancaster, Penn.-based medtech accelerator that opened this week. The accelerator was developed collaboratively by Aspire Ventures, Capital BlueCross, Clio Health and Penn Medicine Lancaster General Health, according to a press release. The incubator lab will provide a 12-week […]

Filed Under: Business/Financial News, Research & Development Tagged With: Athenahealth Inc., CVS Health, Siemens

CVS Health launches drug-pricing tool for pharmacies

April 12, 2018 By Sarah Faulkner

CVS Health (NYSE:CVS) announced this week that it plans to launch a program to help consumers compare drug prices at the pharmacy counter. The company’s Rx Savings Finder program is designed to enable pharmacists to evaluate individual prescriptions and find the lowest cost option for consumers. The tool is available at all CVS Pharmacy locations, the […]

Filed Under: Pharmaceutical, Wall Street Beat Tagged With: CVS Health

CVS offers discount to uninsured for overdose reversal drug

April 6, 2018 By Sarah Faulkner

CVS Health (NYSE:CVS) announced yesterday that it plans to offer a discount for Narcan, the nasal spray designed to reverse the effects of opioid overdoses, to customers who do not have insurance. The company said it will cut the cost of Narcan from its list price of $125 to $94.99 – the lowest price available for […]

Filed Under: Drug-Device Combinations, Pharmaceutical, Wall Street Beat Tagged With: Adapt Pharma, CVS Health, Kaleo Inc

CVS is diving into the dialysis market

April 6, 2018 By Fink Densford

Drug store operator CVS Health (NYSE:CVS) said today it plans to expand into the dialysis market, launching a program focused on early identification of kidney disease and unveiling plans to develop a new home hemodialysis system. CVS said it will approach its entry into the dialysis market in stages, focusing on early disease identification and education, […]

Filed Under: Business/Financial News, Research & Development Tagged With: CVS Health

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS